Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The pill of recovery; Molnupiravir for treatment of COVID-19 patients; a systematic review
Lina Kamal, Ahmed Ramadan, Suha A. Farraj, et al.
Saudi Pharmaceutical Journal (2022) Vol. 30, Iss. 5, pp. 508-518
Open Access | Times Cited: 20

Showing 20 citing articles:

Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life
Luca Cegolon, Riccardo Pol, Omar Simonetti, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 721-721
Open Access | Times Cited: 35
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 31
Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
Kalpana Mali, Madhavi Eerike, Gerard Marshall Raj, et al.
Irish Journal of Medical Science (1971 -) (2022) Vol. 192, Iss. 4, pp. 1665-1678
Open Access | Times Cited: 26
Efficacy of Molnupiravir for the Treatment of Mild or Moderate COVID-19 in Adults: A Meta-Analysis
Karima Benaicha, Raja Ram Khenhrani, Maha Veer, et al.
Cureus (2023)
Open Access | Times Cited: 13
Rapid review and meta‐analysis of adverse events associated with molnupiravir in patients with COVID‐19
Behnam Amani, Sara Zareei, Bahman Amani
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4403-4411
Open Access | Times Cited: 18
Identification of Diosmin and Flavin Adenine Dinucleotide as Repurposing Treatments for Monkeypox Virus: A Computational Study
Thua-Phong Lam, Viet-Hung Tran, Tan Thanh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11570-11570
Open Access | Times Cited: 14
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Viviana De Luca, Andrea Angeli, Alessio Nocentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 971-971
Open Access | Times Cited: 2
Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
Aram Yegiazaryan, Arbi Abnousian, Logan J. Alexander, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9297-9297
Open Access | Times Cited: 11
Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Bahman Amani, Behnam Amani
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 1
Three-step process for the synthesis of favipiravir
Swarnayu Banik, D.R. Adarsh, B. V. Subba Reddy
Results in Chemistry (2023) Vol. 5, pp. 100895-100895
Open Access | Times Cited: 2
Effect of combination of molnupiravir with clarithromycin on blood biomarkers in patients with mild-to-moderate COVID-19
Kenji Gonda, Takeshi Hai, Kouichi Suzuki, et al.
Journal of Clinical and Translational Research (2024) Vol. 10, Iss. 1, pp. 00075-00075
Open Access
Evaluation of COVID-19 preventive practices among sellers in the Beni Mellal region of Morocco
Abouddihaj Barguigua, Ilham Zahir
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 03, pp. 362-370
Open Access
Prevention is better than healing. Clinical and economic implications of oral antiviral agents in COVID-19: a prospective study
Filomena Pietrantonio, Francesco Rosiello, Matteo Ruggeri, et al.
Italian Journal of Medicine (2024) Vol. 18, Iss. 2
Open Access
Insights into SARS-CoV-2: Small-Molecule Hybrids for COVID-19 Treatment
Maria Luisa Navacchia, Caterina Cinti, Elena Marchesi, et al.
Molecules (2024) Vol. 29, Iss. 22, pp. 5403-5403
Open Access
Real-world data concerning the efficacy of molnupiravir in patients vaccinated against COVID-19 during the Omicron surge in Japan
Satoshi Inaba, Naoya Nishioka, Hisatoshi Okumura, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
Weslany Souza Rocha, Peng Zhan, Edeildo Ferreira da Silva‐Júnior
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1625-1639
Closed Access | Times Cited: 1
Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran
Fatemeh Hajizadeh, Tahereh Mikaeili Galeh, Seyed Abdollah Hosseini, et al.
Parasite Epidemiology and Control (2023) Vol. 22, pp. e00312-e00312
Open Access | Times Cited: 1
Prevention Is Better Than Care. Clinical and Economic Implications of Oral Antiviral Agents in COVID 19: A Prospective Study
Filomena Pietrantonio, Francesco Rosiello, Matteo Ruggeri, et al.
(2023)
Open Access | Times Cited: 1
Lessons that can be learned from the SARS-CoV-2 pandemic and their impact on the prophylaxis and treatment development for neglected tropical arboviruses
Danilo Rosa-Nunes, Danilo B. M. Lucchi, Robert Andreata‐Santos, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access
Therapeutic Effects of Clarithromycin Combined with Molnupiravir in Management of Mild to Moderate COVID-19 Hospitalized Patients: A Case Control Study
Kenji Gonda, Kouichi Suzuki, Koji Kono, et al.
SSRN Electronic Journal (2022)
Closed Access
Page 1

Scroll to top